Jazz Pharmaceuticals (JAZZ)

58.68 +0.19  +0.32%  May 21, 11:47AM
Add to Watchlists Create an Alert

Jazz Pharmaceuticals Cash from Investing Quarterly:

-2.443M for March 31, 2013
View Full Chart

Jazz Pharmaceuticals Cash from Investing Quarterly Chart

    Jazz Pharmaceuticals Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -2.443M
    Dec. 31, 2012 87.19M
    Sept. 30, 2012 -3.749M
    June 30, 2012 -561.24M
    March 31, 2012 82.51M
    Dec. 31, 2011 -65.60M
    Sept. 30, 2011 -13.62M
    June 30, 2011 -0.82M
    March 31, 2011 -1.191M
    Dec. 31, 2010 -1.113M
    Sept. 30, 2010 -0.806M
    June 30, 2010 -1.175M
    March 31, 2010 0.951M
       
    Dec. 31, 2009 -5.044M
    Sept. 30, 2009 -1.905M
    June 30, 2009 -0.312M
    March 31, 2009 1.137M
    Dec. 31, 2008 -6.994M
    Sept. 30, 2008 6.22M
    June 30, 2008 -8.241M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    JAZZ Cash from Investing Quarterly Benchmarks

    Companies
    Santarus -1.594M
    Cubist Pharmaceuticals -29.37M
    Catalyst Pharmaceutical Partners -14.05M

    JAZZ Cash from Investing Quarterly Rankings

    Overall 72nd percentile
    2168 of 8002
    Sector 48th percentile
    354 of 684 in Healthcare
    Industry 38th percentile
    152 of 248 in Biotechnology

    JAZZ Cash from Investing Quarterly Range, Past 5 Years

    Minimum -561.24M Jun 2012
    Maximum 87.19M Dec 2012
    Average -24.81M